# Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer

> **NCT01216527** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 430 (estimated)

## Conditions studied

- Squamous Cell Esophageal Carcinoma

## Interventions

- **PROCEDURE:** Neo-adjuvant Chemoradiotherapy followed by Surgery
- **PROCEDURE:** surgery

## Key facts

- **NCT ID:** NCT01216527
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-06
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 430 (ESTIMATED)
- **Last updated:** 2017-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01216527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01216527, "Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01216527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
